Full Issue

Individual Articles - Jul/Aug 2000 - Compounding for Hospice and Cancer Patients

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2000 Pg. 246-249	Hospice and the Role of the Compounding Pharmacist Author(s): Carling Maureen A
Jul/Aug 2000 Pg. 250-251	Nausea and Vomiting in Hospice Patients Author(s): Boomsma Diane
Jul/Aug 2000 Pg. 253-254	Ketamine for Pain in Hospice Patients Author(s): Wood Robert M
Jul/Aug 2000 Pg. 255-256	Custom-Making Medications for the Hospice Patient Author(s): Horwitz Robert
Jul/Aug 2000 Pg. 255	Body-Wash Formula Author(s): Horwitz Robert
Jul/Aug 2000 Pg. 255	Rinseless Shampoo Author(s): Horwitz Robert
Jul/Aug 2000 Pg. 255	Dry Mouth Spray Author(s): Horwitz Robert
Jul/Aug 2000 Pg. 257-260	Surviving Cancer - How the Compounding Pharmacist Can Help Author(s): Maddox Suzan
Jul/Aug 2000 Pg. 261-263	Compounding Using Hazardous Drugs Author(s): Lau Kellie
Jul/Aug 2000 Pg. 264-272	Providing Positive Outcomes through Compounding for Animal Cancer Patients Author(s): Davidson Gigi S
Jul/Aug 2000 Pg. 276-279	Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease Author(s): Glasnapp Andrew, Schaefer Erin
Jul/Aug 2000 Pg. 278	NADH Capsules Author(s): Glasnapp Andrew, Schaefer Erin
Jul/Aug 2000 Pg. 280	Short Communication: Compounding for Implantable Pumps Author(s): Molitor Richard
Jul/Aug 2000 Pg. 281-285	Ambulatory Pumps: Part I of a Three-Part Series - Peristaltic Infusion Devices Review Author(s): Ashworth Lisa D
Jul/Aug 2000 Pg. 287	Profile of a Practice Author(s): Hudson Sonora
Jul/Aug 2000 Pg. 288	Book Reviews Author(s): Reed-Kane Dana
Jul/Aug 2000 Pg. 289-293	Basics of Compounding: Compounding Suppositories: Part I - Theoretical Considerations Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 296	Dacarbazine 8-mg/mL, Doxorubicin HCl 0.8-mg/mL and Ondansetron 0.64-mg/mL injection Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 297	Dexamethasone 1.2%, Lorazepam 0.1%, Haloperidol 0.1%, Diphenhydramine HCl 2.4% and Metoclopramide HCl 2.4% in PLO Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 298	Doxorubicin HCl 0.4-mg/mL, Ondansetron HCl 0.48-mg/mL and Vincristine Sulfate 14-mcg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 299	Fentanyl 100-mcg/0.1-mL and Promethazine HCl 12.5-mg/0.1-mL in PLO Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 300	Fentanyl 35-mcg/mL, Bupivacaine HCl 1-mg/mL and Clonidine HCl 9-mcg/mL Intrathecal Solution Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 301	Lidocaine HCl 2%, Misoprostol 0.003% and Phenytoin 2.5% Topical Gel for Decubitus Ulcers Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 302	Misoprostol 0.0024% Mouth Rinse for Oral Ulcerations Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 303	Morphine Sulfate 20-mg/mL and Clonidine HCl 10-mcg/mL Epidural Injection Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 304	Nasogastric Tube/Percutaneous Endoscopic Gastrostomy Tube Suspension Formula Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 305	Ondansetron HCl 8-mg/mL in PLO Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 306-310	Capsule and Tablet Diluents, Featured Excipient: Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 313-312	Basic Compounding Documentation: The Master Formula Form Author(s): Tenreiro Kim
Jul/Aug 2000 Pg. 314	Calculations Author(s): Prince Shelly J
Jul/Aug 2000 Pg. 315-317	Experimenting with a New Emulsifying Agent (Tahini) in Mineral Oil Emulsion Author(s): Al-Achi Antoine, Greenwood Robert, Akin-Isijola Austin
Jul/Aug 2000 Pg. 318-319	Microbiological Stability of a Fentanyl, Bupivacaine and Clonidine Mixture in a 0.9% Sodium Chloride Infusion Stored in Syringes and Reservoirs Author(s): Jappinen Annaliisa L, Naaranlahti Toivo J, Kokki Hannu, Ojanen Tarja, Rasi Anu
Jul/Aug 2000 Pg. 320-323	Stability of 5-Fluorouracil in an Extemporaneously Compounded Ophthalmic Solution Author(s): Fuhrman L Clifton, Godwin Donald A, Davis R Alan